Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16089-44-4

Post Buying Request

16089-44-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16089-44-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 16089-44-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,8 and 9 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 16089-44:
(7*1)+(6*6)+(5*0)+(4*8)+(3*9)+(2*4)+(1*4)=114
114 % 10 = 4
So 16089-44-4 is a valid CAS Registry Number.

16089-44-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-chloro-4-pyrrolidin-1-ylaniline

1.2 Other means of identification

Product number -
Other names 3-Chloro-4-pyrrolidin-1-yl-phenylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16089-44-4 SDS

16089-44-4Downstream Products

16089-44-4Relevant articles and documents

MICROANGIOPATHY TREATMENT AND PREVENTION

-

, (2010/07/04)

The present invention relates to the use of selective factor Xa inhibitors, in particular of oxazolidinones of the formula (I) for the treatment and/or prophylaxis of microangiopathies and also their use for the production of medicaments for the treatment and/or prophylaxis of microangiopathies.

Substituted oxazolidinones and their in the field of blood coagulation

-

, (2008/06/13)

The invention relates to the field of blood coagulation. Novel oxazolidinone derivatives of the general formula (I) processes for their preparation and their use as medicinally active compounds for the prophylaxis and/or treatment of disorders are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16089-44-4